GPN Vaccines Ltd.

Universal Streptococcus Pneumoniae Vaccine, single strain, safe because inactivated by gamma radiation, easy to produce, with the potential to chase Prevenar

  • Stage Product In Development
  • Industry Biotechnology
  • Location Sydney NSW, Australia
  • Currency AUD
  • Founded September 2017
  • Employees 1
  • Incorporation Type LLC
  • Website gpnvaccines.com

Company Summary

- AUD 1M NHMRC grant awarded (11-Oct-2017); and AUD 0.3M grant awarded from the South Australian Government (17-Dec-2017)
- World-class team from day 1
- Multi-billion dollar market opportunity as this vaccine has the potential to challenge Prevnar
- A couple of scientifc advisory board members played a pivotal role in the development of Prevnar
- Business model is to develop until phase II and divest

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free